Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial

Published:2017-07-10 Issue:1 Volume:9 Page:119-126
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Miya Aika¹²^ORCID,Nakamura Akinobu¹^ORCID,Miyoshi Hideaki¹,Cho Kyu Yong¹,Nagai So³,Kurihara Yoshio⁴,Aoki Shin⁵,Taguri Masataka⁶,Terauchi Yasuo⁷,Atsumi Tatsuya¹

Affiliation:

1. Division of Rheumatology, Endocrinology and Nephrology; Hokkaido University Graduate School of Medicine; Sapporo Japan

2. Kushiro Red Cross Hospital; Kushiro Japan

3. Sapporo Medical Center NTT EC; Sapporo Japan

4. Kurihara Clinic; Sapporo Japan

5. Aoki Clinic; Sapporo Japan

6. Department of Biostatistics; Yokohama City University; Yokohama Japan

7. Department of Endocrinology and Metabolism; Graduate School of Medicine; Yokohama City University; Yokohama Japan

Funder

Sanofi

Astellas Pharma

AstraZeneca

Dainippon Sumitomo Pharma

Eli Lilly and Company

Kissei

Mitsubishi Tanabe Pharma Co.

MSD

Novartis Pharma

Novo Nordisk Pharma

Takeda Pharmaceutical Company

Taisho Toyama Pharmaceutical Company

Ono Pharmaceutical Co., Ltd.

Nippon Boehringer Ingelheim Co., Ltd.

Daiichi-Sankyo

Sanwa Kagaku Kenkyusho Co., Ltd.

Bayer

Shionogi

Kowa Pharmaceutical Co., Ltd.

Pfizer

Chugai Pharmaceutical

AbbVie

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12654/fullpdf

Reference30 articles.

1. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease;Prospective Diabetes Study Group;Diabetes,1995

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);United Kingdom Prospective Diabetes Study (UKPDS) Group;Lancet,1998

3. Three-year efficacy of complex insulin regimens in type 2 diabetes;Holman;N Engl J Med,2009

4. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57);Wright;Diabetes Care,2002

5. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetologia,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐reported outcomes in studies of diabetes technology: What matters;Diabetes, Obesity and Metabolism;2024-08-31

2. The Impact of Myosteatosis on Cardiac Function in a Healthy Population: Insights from Abdominal CT Imaging;2024-08-04

3. The effect of subcutaneous Lixisenatide on weight loss in patients with type 2 Diabetes Mellitus: Systematic review and Meta-Analysis of randomized controlled trials;Diabetes Research and Clinical Practice;2024-04

4. Simplification of Complex Insulin Regimens with IdegLira in People with Type 2 Diabetes: Literature Review and Clinical Recommendations;Diabetes Therapy;2023-09-22

5. GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis;Frontiers in Endocrinology;2023-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3